Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
475108-18-0
Purity
95%
Tivozanib is a tyrosine kinase inhibitor that exerts its actions by inhibiting the phosphorylation of vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2 and VEGFR-3 and inhibits other kinases such as c-kit and platelet derived growth factor beta. Tivozanib is used to treat adult patients with renal cell carcinoma who have failed prior systemic therapies or experienced relapsed disease.
Properties
Name
Tivozanib
Smiles
COC=1C=C2N=CC=C(OC=3C=CC(NC(=O)NC=4C=C(C)ON4)=C(Cl)C3)C2=CC1OC
Targets
Please log in to see this information
SDS
Av-951 | KRN951 | tivozanib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$57
2 mg
$62
5 mg
$67
10 mg
$85
15 mg
$93
20 mg
$101
25 mg
$113
30 mg
$121
35 mg
$130
40 mg
$146
45 mg
$156
50 mg
$169
75 mg
$240
100 mg
$285
Quantity
1
Total amount
$ 67
Av-951 | KRN951 | tivozanib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:682745-41-1
0
CAS:682745-43-3
0